BYRN

Item 4 of the Schedule 13D is hereby amended and supplemented as follows (which shall be in addition to the information previously included in the Schedule 13D): The Reporting Persons are making this filing to disclose the following information: Mr. Ganz has had substantive conversations with five of the seven of the Company's board members over the last week regarding the composition of the Board and the "pivot" in the marketing program that was implemented after Mr. Ganz's departure that, in his view, has resulted in the Company's recent significant decline in sales and profits. As part of these conversations, Mr. Ganz provided the names of two highly qualified board candidates, each of whom have built businesses worth hundreds of millions or billions of dollars over their careers and each of whom have served on numerous public boards, including the boards of multi-billion dollar businesses. It is rare to find candidates of their caliber on the boards of $100 million companies, however, both board candidates have experience in the less-lethal space and fully embrace the Company's mission of saving lives. The Chairman of the Board, TJ Kennedy, has informed Mr. Ganz that he has contacted these candidates and initiated discussions, and told Mr. Ganz that he is "very excited about the prospect of upgrading the board." Mr. Ganz looks forward to working cooperatively with the Company's board and supporting them in their effort to upgrade the board as the Company looks to reignite growth and restore profitability.

Item 4 of the Schedule 13D is hereby amended and supplemented as follows (which shall be in addition to the information previously included in the Schedule 13D): The Reporting Persons are making this filing to disclose the following information: Mr. Ganz has had substantive conversations with five of the seven of the Company's board members over the last week regarding the composition of the Board and the "pivot" in the marketing program that was implemented after Mr. Ganz's departure that, in his view, has resulted in the Company's recent significant decline in sales and profits. As part of these conversations, Mr. Ganz provided the names of two highly qualified board candidates, each of whom have built businesses worth hundreds of millions or billions of dollars over their careers and each of whom have served on numerous public boards, including the boards of multi-billion dollar businesses. It is rare to find candidates of their caliber on the boards of $100 million companies, however, both board candidates have experience in the less-lethal space and fully embrace the Company's mission of saving lives. The Chairman of the Board, TJ Kennedy, has informed Mr. Ganz that he has contacted these candidates and initiated discussions, and told Mr. Ganz that he is "very excited about the prospect of upgrading the board." Mr. Ganz looks forward to working cooperatively with the Company's board and supporting them in their effort to upgrade the board as the Company looks to reignite growth and restore profitability.

Item 4 of the Schedule 13D is hereby amended and supplemented as follows (which shall be in addition to the information previously included in the Schedule 13D): The Reporting Persons are making this filing to disclose the following information: Mr. Ganz has had substantive conversations with five of the seven of the Company's board members over the last week regarding the composition of the Board and the "pivot" in the marketing program that was implemented after Mr. Ganz's departure that, in his view, has resulted in the Company's recent significant decline in sales and profits. As part of these conversations, Mr. Ganz provided the names of two highly qualified board candidates, each of whom have built businesses worth hundreds of millions or billions of dollars over their careers and each of whom have served on numerous public boards, including the boards of multi-billion dollar businesses. It is rare to find candidates of their caliber on the boards of $100 million companies, however, both board candidates have experience in the less-lethal space and fully embrace the Company's mission of saving lives. The Chairman of the Board, TJ Kennedy, has informed Mr. Ganz that he has contacted these candidates and initiated discussions, and told Mr. Ganz that he is "very excited about the prospect of upgrading the board." Mr. Ganz looks forward to working cooperatively with the Company's board and supporting them in their effort to upgrade the board as the Company looks to reignite growth and restore profitability.

Item 4 of the Schedule 13D is hereby amended and supplemented as follows (which shall be in addition to the information previously included in the Schedule 13D): The Reporting Persons are making this filing to disclose the following information: Mr. Ganz has had substantive conversations with five of the seven of the Company's board members over the last week regarding the composition of the Board and the "pivot" in the marketing program that was implemented after Mr. Ganz's departure that, in his view, has resulted in the Company's recent significant decline in sales and profits. As part of these conversations, Mr. Ganz provided the names of two highly qualified board candidates, each of whom have built businesses worth hundreds of millions or billions of dollars over their careers and each of whom have served on numerous public boards, including the boards of multi-billion dollar businesses. It is rare to find candidates of their caliber on the boards of $100 million companies, however, both board candidates have experience in the less-lethal space and fully embrace the Company's mission of saving lives. The Chairman of the Board, TJ Kennedy, has informed Mr. Ganz that he has contacted these candidates and initiated discussions, and told Mr. Ganz that he is "very excited about the prospect of upgrading the board." Mr. Ganz looks forward to working cooperatively with the Company's board and supporting them in their effort to upgrade the board as the Company looks to reignite growth and restore profitability.

Item 4 of the Schedule 13D is hereby amended and supplemented as follows (which shall be in addition to the information previously included in the Schedule 13D): The Reporting Persons are making this filing to disclose the following information: Mr. Ganz has had substantive conversations with five of the seven of the Company's board members over the last week regarding the composition of the Board and the "pivot" in the marketing program that was implemented after Mr. Ganz's departure that, in his view, has resulted in the Company's recent significant decline in sales and profits. As part of these conversations, Mr. Ganz provided the names of two highly qualified board candidates, each of whom have built businesses worth hundreds of millions or billions of dollars over their careers and each of whom have served on numerous public boards, including the boards of multi-billion dollar businesses. It is rare to find candidates of their caliber on the boards of $100 million companies, however, both board candidates have experience in the less-lethal space and fully embrace the Company's mission of saving lives. The Chairman of the Board, TJ Kennedy, has informed Mr. Ganz that he has contacted these candidates and initiated discussions, and told Mr. Ganz that he is "very excited about the prospect of upgrading the board." Mr. Ganz looks forward to working cooperatively with the Company's board and supporting them in their effort to upgrade the board as the Company looks to reignite growth and restore profitability.

Item 4 of the Schedule 13D is hereby amended and supplemented as follows (which shall be in addition to the information previously included in the Schedule 13D): The Reporting Persons are making this filing to disclose the following information: Mr. Ganz has had substantive conversations with five of the seven of the Company's board members over the last week regarding the composition of the Board and the "pivot" in the marketing program that was implemented after Mr. Ganz's departure that, in his view, has resulted in the Company's recent significant decline in sales and profits. As part of these conversations, Mr. Ganz provided the names of two highly qualified board candidates, each of whom have built businesses worth hundreds of millions or billions of dollars over their careers and each of whom have served on numerous public boards, including the boards of multi-billion dollar businesses. It is rare to find candidates of their caliber on the boards of $100 million companies, however, both board candidates have experience in the less-lethal space and fully embrace the Company's mission of saving lives. The Chairman of the Board, TJ Kennedy, has informed Mr. Ganz that he has contacted these candidates and initiated discussions, and told Mr. Ganz that he is "very excited about the prospect of upgrading the board." Mr. Ganz looks forward to working cooperatively with the Company's board and supporting them in their effort to upgrade the board as the Company looks to reignite growth and restore profitability.